+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Atranorin Market by Source (Natural, Synthetic), Application (Cosmetics, Pharmaceuticals, Research & Development) - Forecast 2024-2030

  • PDF Icon

    Report

  • 185 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 5968185
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Atranorin Market size was estimated at USD 78.01 million in 2023, USD 81.27 million in 2024, and is expected to grow at a CAGR of 4.30% to reach USD 104.82 million by 2030.

Atranorin is a secondary metabolite primarily found in many species of lichens, serving both as a deterrent to herbivores and a protection against microbial invasion. As a compound, atranorin exhibits a range of bioactive properties, including antimicrobial, anti-inflammatory, and antioxidative effects, which are central to its growing appeal in various applications. The major factors behind the expansion of atranorin's use lie in its potential within pharmaceuticals, cosmetics, and dietary supplements, propelled by rising consumer demand for natural and sustainable products. This shift towards greener alternatives has encouraged more in-depth research and exploration of atranorin's benefits.

However, challenges in the utilization of atranorin stem from sustainability concerns regarding lichen harvesting and the complexity of synthesizing the compound artificially. Despite these challenges, advances in biotechnology may offer more sustainable and efficient methods of producing atranorin, either through improved extraction techniques or synthetic biology approaches. In addition, expanding knowledge of the properties of atranorin could open up new application fields and drive demand further.

Regional Insights

In the Americas, there is a growing interest in natural and sustainable products, which has positively influenced the Atranorin market. The demand is further driven by the pharmaceutical and cosmetic sectors seeking natural ingredients for product development. The EMEA region showcases a variable market performance for Atranorin, with demand in robust cosmetics and pharmaceutical industries. The European market benefits from high consumer awareness regarding the use of natural ingredients and stringent safety regulations, encouraging the use of substances including Atranorin in product formulations. The Middle East and Africa show potential for market expansion within the cosmetics sector.

Asia-Pacific is witnessing the fastest growth in the Atranorin market, mainly owing to rapid industrialization and an expanding middle class with increasing disposable income. Countries including China and India contribute majorly, driven by booming pharmaceutical and cosmetics industries. The APAC market benefits from a vast base of raw material supply, especially from lichen-rich areas, and a strong consumer trend towards natural and organic products. This region's growing awareness and economic development suggest a promising future for the Atranorin market.

Market Trends by Segment

  • Source: Significance of synthetic sources for mass production of atranorin
  • Application: Growing adoption of atranorin in pharmaceuticals owing to its therapeutic benefits

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

Shroom boom Unveiled the Potential of Mycocosmetics in the Beauty Industry

The skincare and cosmetics brand Shroom boom introduces new fungi-based ingredients. These ingredients are preferred for their potent properties which include anti-inflammatory, antioxidant, and hydrating effects. The launch of this product reflects a broader industry move towards natural, sustainable, and biologically active components.

Key Company Profiles

The report delves into recent significant developments in the Atranorin Market, highlighting leading vendors and their innovative profiles. These include BioCrick Co., Ltd., Biosynth Ltd, BOCSCI Inc., Cayman Chemical Company, ChemScene, Hunan Huateng Pharmaceutical Co., Ltd., Merck KGaA, Pharmaffiliates, Procurenet, and Wuhan ChemFaces Biochemical Co., Ltd.

This research report offers invaluable insights into various crucial aspects of the Atranorin Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increased demand of atranorin in cosmetic industries
5.1.1.2. Robust trend towards natural and organic products
5.1.2. Restraints
5.1.2.1. Fluctuating availability of natural atranorin and raw materials associated with atranorin production
5.1.3. Opportunities
5.1.3.1. Ongoing research into the potential applications of atranorin
5.1.3.2. Growing pontential of atranorin in pharmaceutical applications
5.1.4. Challenges
5.1.4.1. Issues over extraction complexities of atranorin and scale of operations
5.2. Market Segmentation Analysis
5.2.1. Source: Significance of synthetic sources for mass production of atranorin
5.2.2. Application: Growing adoption of atranorin in pharmaceuticals owing to its therapeutic benefits
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Atranorin Market, by Source
6.1. Introduction
6.2. Natural
6.3. Synthetic
7. Atranorin Market, by Application
7.1. Introduction
7.2. Cosmetics
7.3. Pharmaceuticals
7.4. Research & Development
8. Americas Atranorin Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Atranorin Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Atranorin Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. Market Share Analysis, 2023
11.2. FPNV Positioning Matrix, 2023
11.3. Competitive Scenario Analysis
11.3.1. Shroom boom Unveiled the Potential of Mycocosmetics in the Beauty Industry
11.4. Strategy Analysis & Recommendation
12. Competitive Portfolio
12.1. Key Company Profiles
12.2. Key Product Portfolio
List of Figures
FIGURE 1. ATRANORIN MARKET RESEARCH PROCESS
FIGURE 2. ATRANORIN MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL ATRANORIN MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL ATRANORIN MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL ATRANORIN MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. ATRANORIN MARKET DYNAMICS
FIGURE 7. GLOBAL ATRANORIN MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
FIGURE 8. GLOBAL ATRANORIN MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ATRANORIN MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. GLOBAL ATRANORIN MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS ATRANORIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 12. AMERICAS ATRANORIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES ATRANORIN MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 14. UNITED STATES ATRANORIN MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC ATRANORIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC ATRANORIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ATRANORIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ATRANORIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ATRANORIN MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 20. ATRANORIN MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. ATRANORIN MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL ATRANORIN MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL ATRANORIN MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL ATRANORIN MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL ATRANORIN MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL ATRANORIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL ATRANORIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL ATRANORIN MARKET SIZE, BY NATURAL, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL ATRANORIN MARKET SIZE, BY NATURAL, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL ATRANORIN MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL ATRANORIN MARKET SIZE, BY SYNTHETIC, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL ATRANORIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL ATRANORIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL ATRANORIN MARKET SIZE, BY COSMETICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL ATRANORIN MARKET SIZE, BY COSMETICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL ATRANORIN MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL ATRANORIN MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL ATRANORIN MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL ATRANORIN MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. AMERICAS ATRANORIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 22. AMERICAS ATRANORIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 23. AMERICAS ATRANORIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 24. AMERICAS ATRANORIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 25. AMERICAS ATRANORIN MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 26. AMERICAS ATRANORIN MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 27. ARGENTINA ATRANORIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 28. ARGENTINA ATRANORIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 29. ARGENTINA ATRANORIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 30. ARGENTINA ATRANORIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 31. BRAZIL ATRANORIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 32. BRAZIL ATRANORIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 33. BRAZIL ATRANORIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 34. BRAZIL ATRANORIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 35. CANADA ATRANORIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 36. CANADA ATRANORIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 37. CANADA ATRANORIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 38. CANADA ATRANORIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 39. MEXICO ATRANORIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 40. MEXICO ATRANORIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 41. MEXICO ATRANORIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 42. MEXICO ATRANORIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 43. UNITED STATES ATRANORIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 44. UNITED STATES ATRANORIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 45. UNITED STATES ATRANORIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 46. UNITED STATES ATRANORIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 47. UNITED STATES ATRANORIN MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 48. UNITED STATES ATRANORIN MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 49. ASIA-PACIFIC ATRANORIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 50. ASIA-PACIFIC ATRANORIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 51. ASIA-PACIFIC ATRANORIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 52. ASIA-PACIFIC ATRANORIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 53. ASIA-PACIFIC ATRANORIN MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 54. ASIA-PACIFIC ATRANORIN MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 55. AUSTRALIA ATRANORIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 56. AUSTRALIA ATRANORIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 57. AUSTRALIA ATRANORIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 58. AUSTRALIA ATRANORIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 59. CHINA ATRANORIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 60. CHINA ATRANORIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 61. CHINA ATRANORIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 62. CHINA ATRANORIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 63. INDIA ATRANORIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 64. INDIA ATRANORIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 65. INDIA ATRANORIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 66. INDIA ATRANORIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 67. INDONESIA ATRANORIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 68. INDONESIA ATRANORIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 69. INDONESIA ATRANORIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 70. INDONESIA ATRANORIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 71. JAPAN ATRANORIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 72. JAPAN ATRANORIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 73. JAPAN ATRANORIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 74. JAPAN ATRANORIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 75. MALAYSIA ATRANORIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 76. MALAYSIA ATRANORIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 77. MALAYSIA ATRANORIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 78. MALAYSIA ATRANORIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 79. PHILIPPINES ATRANORIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 80. PHILIPPINES ATRANORIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 81. PHILIPPINES ATRANORIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 82. PHILIPPINES ATRANORIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 83. SINGAPORE ATRANORIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 84. SINGAPORE ATRANORIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 85. SINGAPORE ATRANORIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 86. SINGAPORE ATRANORIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 87. SOUTH KOREA ATRANORIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 88. SOUTH KOREA ATRANORIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 89. SOUTH KOREA ATRANORIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 90. SOUTH KOREA ATRANORIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 91. TAIWAN ATRANORIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 92. TAIWAN ATRANORIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 93. TAIWAN ATRANORIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 94. TAIWAN ATRANORIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 95. THAILAND ATRANORIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 96. THAILAND ATRANORIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 97. THAILAND ATRANORIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 98. THAILAND ATRANORIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 99. VIETNAM ATRANORIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 100. VIETNAM ATRANORIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 101. VIETNAM ATRANORIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 102. VIETNAM ATRANORIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA ATRANORIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA ATRANORIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA ATRANORIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA ATRANORIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA ATRANORIN MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA ATRANORIN MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 109. DENMARK ATRANORIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 110. DENMARK ATRANORIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 111. DENMARK ATRANORIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 112. DENMARK ATRANORIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 113. EGYPT ATRANORIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 114. EGYPT ATRANORIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 115. EGYPT ATRANORIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 116. EGYPT ATRANORIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 117. FINLAND ATRANORIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 118. FINLAND ATRANORIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 119. FINLAND ATRANORIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 120. FINLAND ATRANORIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 121. FRANCE ATRANORIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 122. FRANCE ATRANORIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 123. FRANCE ATRANORIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 124. FRANCE ATRANORIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 125. GERMANY ATRANORIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 126. GERMANY ATRANORIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 127. GERMANY ATRANORIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 128. GERMANY ATRANORIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 129. ISRAEL ATRANORIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 130. ISRAEL ATRANORIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 131. ISRAEL ATRANORIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 132. ISRAEL ATRANORIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 133. ITALY ATRANORIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 134. ITALY ATRANORIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 135. ITALY ATRANORIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 136. ITALY ATRANORIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 137. NETHERLANDS ATRANORIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 138. NETHERLANDS ATRANORIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 139. NETHERLANDS ATRANORIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 140. NETHERLANDS ATRANORIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 141. NIGERIA ATRANORIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 142. NIGERIA ATRANORIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 143. NIGERIA ATRANORIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 144. NIGERIA ATRANORIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 145. NORWAY ATRANORIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 146. NORWAY ATRANORIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 147. NORWAY ATRANORIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 148. NORWAY ATRANORIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 149. POLAND ATRANORIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 150. POLAND ATRANORIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 151. POLAND ATRANORIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 152. POLAND ATRANORIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 153. QATAR ATRANORIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 154. QATAR ATRANORIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 155. QATAR ATRANORIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 156. QATAR ATRANORIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 157. RUSSIA ATRANORIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 158. RUSSIA ATRANORIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 159. RUSSIA ATRANORIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 160. RUSSIA ATRANORIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 161. SAUDI ARABIA ATRANORIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 162. SAUDI ARABIA ATRANORIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 163. SAUDI ARABIA ATRANORIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 164. SAUDI ARABIA ATRANORIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA ATRANORIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 166. SOUTH AFRICA ATRANORIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA ATRANORIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 168. SOUTH AFRICA ATRANORIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 169. SPAIN ATRANORIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 170. SPAIN ATRANORIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 171. SPAIN ATRANORIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 172. SPAIN ATRANORIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 173. SWEDEN ATRANORIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 174. SWEDEN ATRANORIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 175. SWEDEN ATRANORIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 176. SWEDEN ATRANORIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 177. SWITZERLAND ATRANORIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 178. SWITZERLAND ATRANORIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 179. SWITZERLAND ATRANORIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 180. SWITZERLAND ATRANORIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 181. TURKEY ATRANORIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 182. TURKEY ATRANORIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 183. TURKEY ATRANORIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 184. TURKEY ATRANORIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES ATRANORIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES ATRANORIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES ATRANORIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 188. UNITED ARAB EMIRATES ATRANORIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM ATRANORIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 190. UNITED KINGDOM ATRANORIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM ATRANORIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 192. UNITED KINGDOM ATRANORIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 193. ATRANORIN MARKET SHARE, BY KEY PLAYER, 2023
TABLE 194. ATRANORIN MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

  • BioCrick Co., Ltd.
  • Biosynth Ltd
  • BOCSCI Inc.
  • Cayman Chemical Company
  • ChemScene
  • Hunan Huateng Pharmaceutical Co., Ltd.
  • Merck KGaA
  • Pharmaffiliates
  • Procurenet
  • Wuhan ChemFaces Biochemical Co., Ltd.

Methodology

Loading
LOADING...

Table Information